1. Avan A, Digaleh H, Di Napoli M, et al. Socioeconomic status and stroke incidence, prevalence, mortality, and worldwide burden: an ecological analysis from the Global Burden of Disease Study 2017. BMC Med. 2019;17(1):191. doi:10.1186/s12916-019-1397-3
2. Zhang T, Jiang Y, Zhang S, et al. The association between homocysteine and ischemic stroke subtypes in Chinese: a meta-analysis. Medicine (Baltimore). 2020;99(12):e19467. doi:10.1097/MD.0000000000019467
3. Libby P. Inflammation in atherosclerosis. Nature. 2002;420(6917):868-874. doi:10.1038/nature01323
4. Corrado E, Rizzo M, Coppola G, et al. An update on the role of markers of inflammation in atherosclerosis. J Atheroscler Thromb. 2010;17(1):1-11. doi:10.5551/jat.2600
5. Musunuru K, Kral BG, Blumenthal RS, et al. The use of high-sensitivity assays for C-reactive protein in clinical practice. Nat Clin Pract Cardiovasc Med. 2008;5(10):621-635. doi:10.1038/ncpcardio1322
6. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336(14):973-979. doi:10. 1056/NEJM199704033361401
7. Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010;375(9709):132-140. doi:10.1016/S0140-6736(09)61717-7
8. Dong X, Gao J, Zhang CY, Hayworth C, Frank M, Wang Z. Neutrophil membrane-derived nanovesicles alleviate inflammation to protect mouse brain injury from ischemic stroke. ACS Nano. 2019;13(2):1272-1283. doi: 10.1021/acsnano.8b0657
9. Zhu B, Pan Y, Jing J, et al. Neutrophil counts, neutrophil ratio, and new stroke in minor ischemic stroke or TIA. Neurology. 2018;90(21):e1870- e1878. doi:10.1212/WNL.0000000000005554
10. Farah R, Samra N. Mean platelets volume and neutrophil to lymphocyte ratio as predictors of stroke. J Clin Lab Anal. 2018;32(1):e22189. doi:10. 1002/jcla.22189
11. Cochran KA, Cavallari LH, Shapiro NL, Bishop JR. Bleeding incidence with concomitant use of antidepressants and warfarin. Ther Drug Monit. 2011;33(4):433-438. doi:10.1097/FTD.0b013e318224996e
12. Sansanayudh N, Numthavaj P, Muntham D, et al. Prognostic effect of mean platelet volume in patients with coronary artery disease. A systematic review and meta-analysis. Thromb Haemost. 2015;114(6): 1299-1309. doi:10.1160/TH15-04-0280
13. Zheng M, Chen S, Zhu Y, Gu X. Mean platelet volume: a new predictor of ischaemic stroke risk in patients with nonvalvular atrial fibrillation. BMC Cardiovasc Disord. 2020;20(1):241. doi:10.1186/s12872-020-01525-x
14. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347(20): 1557-1565. doi:10.1056/NEJMoa021993
15. Sharp FR, Lu A, Tang Y, Millhorn DE. Multiple molecular penumbras after focal cerebral ischemia. J Cereb Blood Flow Metab. 2000;20(7):1011-1032. doi:10.1097/00004647-200007000-00001
16. Siesjö BK. Pathophysiology and treatment of focal cerebral ischemia. Part I: Pathophysiology. J Neurosurg. 1992;77(2):169-184. doi:10.3171/jns.1992.77.2.0169
17. Beamer NB, Coull BM, Clark WM, Briley DP, Wynn M, Sexton G. Persistent inflammatory response in stroke survivors. Neurology. 1998; 50(6):1722-1728. doi:10.1212/wnl.50.6.1722
18. Montaner J, Fernandez-Cadenas I, Molina CA, et al. Poststroke C-reactive protein is a powerful prognostic tool among candidates for thrombolysis. Stroke. 2006;37(5):1205-1210. doi:10.1161/01.STR.0000217744.89208.4e
19. Muir KW, Weir CJ, Alwan W, Squire IB, Lees KR. C-reactive protein and outcome after ischemic stroke. Stroke. 1999;30(5):981-985. doi:10. 1161/01.str.30.5.981
20. Di Napoli M, Papa F, Bocola V. C-reactive protein in ischemic stroke: an independent prognostic factor. Stroke. 2001;32(4):917-924. doi:10.1161/ 01.str.32.4.917
21. Rust R, Grönnert L, Schwab ME. Inflammation after stroke: a local rather than systemic response? Trends Neurosci. 2018;41(12):877-879. doi:10.1016/j.tins.2018.09.011
22. Macrez R, Ali C, Toutirais O, et al. Stroke and the immune system: from pathophysiology to new therapeutic strategies. Lancet Neurol. 2011;10(5):471-480. doi:10.1016/S1474-4422(11)70066-7
23. Duan Z, Wang H, Wang Z, et al. Neutrophil-lymphocyte ratio predicts functional and safety outcomes after endovascular treatment for acute ischemic stroke. Cerebrovasc Dis. 2018;45(5-6):221-227. doi:10. 1159/000489401
24. Yamamoto Y, Osanai T, Nishizaki F, et al. Matrix metalloprotein-9 activation under cell-to-cell interaction between endothelial cells and monocytes: possible role of hypoxia and tumor necrosis factor-?. Heart Vessels. 2012;27(6):624-633. doi:10.1007/s00380-011-0214-5
25. Ceulemans AG, Zgavc T, Kooijman R, Hachimi-Idrissi S, Sarre S, Michotte Y. The dual role of the neuroinflammatory response after ischemic stroke: modulatory effects of hypothermia. J Neuroinflammation. 2010;7:74. doi:10.1186/1742-2094-7-74
26. Xu XR, Zhang D, Oswald BE, et al. Platelets are versatile cells: new discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond. Crit Rev Clin Lab Sci. 2016;53(6):409-430. doi:10.1080/10408363.2016.1200008
27. Goyal N, Tsivgoulis G, Chang JJ, et al. Admission neutrophil-to-lymphocyte ratio as a prognostic biomarker of outcomes in large vessel occlusion strokes. Stroke. 2018;49(8):1985-1987. doi:10.1161/STROKEAHA.118.021477
28. Gong P, Liu Y, Gong Y, et al. The association of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and lymphocyte to monocyte ratio with post-thrombolysis early neurological outcomes in patients with acute ischemic stroke. J Neuroinflammation. 2021;18(1):51. doi:10.1186/s12974-021-02090-6
29. Zhu F, Ji Y, Song JH, Huang GX, Zhang YF. Correlations between NLR, NHR, and clinicopathological characteristics, and prognosis of acute ischemic stroke. Medicine (Baltimore). 2023;102(24):e33957. doi:10. 1097/MD.0000000000033957
30. Bath P, Algert C, Chapman N, Neal B; PROGRESS Collaborative Group. Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease. Stroke. 2004;35(3): 622-626. doi:10.1161/01.STR.0000116105.26237.EC
31. Sadeghi F, Kovács S, Zsóri KS, Csiki Z, Bereczky Z, Shemirani AH. Platelet count and mean volume in acute stroke: a systematic review and meta-analysis. Platelets. 2020;31(6):731-739. doi:10.1080/09537104.2019. 1680826
32. Sarkar RN, Das CK, Bhattacharjee U, Banerjee M. Platelet indices as a marker of severity in non-diabetic, non-hypertensive acute ischemic stroke patients. J Assoc Physicians India. 2018;66(7):40-42.
33. Zheng YY, Wang L, Shi Q. Mean platelet volume (MPV) and platelet distribution width (PDW) predict clinical outcome of acute ischemic stroke: a systematic review and meta-analysis. J Clin Neurosci. 2022;101: 221-227. doi:10.1016/j.jocn.2022.05.019
34. Ludhiadch A, Sulena, Singh S, et al. Genomic variation affecting MPV and PLT count in association with development of ischemic stroke and its subtypes. Mol Neurobiol. 2023;60(11):6424-6440. doi:10.1007/s12035-023-03460-2
35. Iadecola C, Buckwalter MS, Anrather J. Immune responses to stroke: mechanisms, modulation, and therapeutic potential. J Clin Invest. 2020; 130(6):2777-2788. doi:10.1172/JCI135530
36. Liesz A, Dalpke A, Mracsko E, et al. DAMP signaling in post-ischemic brain inflammation. Nat Rev Neurol. 2021;17(3):133-149. doi:10.1523/JNEUROSCI.2439-14.2015
37. Jayaraj RL, Azimullah S, Beiram R, Jalal FY, Rosenberg GA. Neuroinflammation: friend and foe for ischemic stroke. J Neuroinflammation. 2019;16(1):142. doi:10.1186/s12974-019-1516-2
38. Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:754. doi:10.3389/fimmu.2018.00754
39. Wang L, Song Q, Wang C et al. Neutrophil to lymphocyte ratio predicts poor outcomes after acute ischemic stroke: a cohort study and systematic review. J Neurol Sci. 2019;406:116445. doi:10.1016/j.jns. 2019.116445
40. Bian J, Guo S, Huang T et al. CRP as a potential predictor of outcome in acute ischemic stroke. Biomed Rep. 2023;18(2):17. doi:10.3892/br. 2023.1599
41. Laridan E, Denorme F, Desender L, et al. Neutrophil extracellular traps in ischemic stroke thrombi. Ann Neurol. 2020;87(2):223-238.
42. Hunkler HJ, Groß S, Thum T, Bär C. Non-coding RNAs: key regulators of reprogramming, pluripotency, and cardiac cell specification with therapeutic perspective for heart regeneration. Cardiovasc Res. 2022; 118(15):3071-3084. doi:10.1093/cvr/cvab335
43. Lyden P, Raman R, Liu L, Emr M, Warren M, Marler J. National Institutes of Health Stroke Scale certification is reliable across multiple venues. Stroke. 2009;40(7):2507-2511. doi:10.1161/STROKEAHA.108.532069
44. Zhang J, Ren Q, Song Y. Prognostic role of neutrophil-lymphocyte ratio in patients with acute ischemic stroke. Medicine (Baltimore). 2017; 96(45):e8624. doi: 10.1097/MD.0000000000008624
45. Chu SG, Becker RC, Berger PB, et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost. 2010;8(1):148-156. doi:10.1111/j.1538-7836.2009.03584.x
46. Zarbock A, Polanowska-Grabowska RK, Ley K. Platelet-neutrophil-interactions: linking hemostasis and inflammation. Blood Rev. 2007; 21(2):99-111. doi:10.1016/j.blre.2006.06.001
47. Zheng YY, Wang L, Shi Q. MPV predicts clinical outcome of acute ischemic stroke: meta-analysis. J Clin Neurosci. 2022;101:221-227.